IPEC Europe welcomes the objectives of the proposed Biotech Act, particularly efforts to strengthen the resilience and strategic autonomy of the EU biotechnology ecosystem. However, the proposal does not explicitly recognise the essential role of pharmaceutical excipients in biotechnology value chains.
IPEC Europe
Industry association · Belgium · EU Transparency Register 341962119314-36
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #1089 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- IPEC Europe is member of IPEC Federation (ipec.org) and of EXCiPACT (excipact.org)
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Trade and business associations
- Registered as
- Le Conseil International des Excipients Pharmaceutiques - Europe (IPEC Europe)
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track IPEC in PolicySpeak: request access →
Work at IPEC Europe? so we know who speaks for it.
Their record over time
IPEC Europe filed 1 position on 4 Aug 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from IPEC Europe’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.